Shareholders Must Cover Successors' Costs In Aspirin Suit
A New Jersey state appeals court said Friday that onetime majority shareholders of Cispharma Inc. were still on the hook for more than $250,000 for their successors' costs in a suit...To view the full article, register now.
Already a subscriber? Click here to view full article